The Clinical and Medical Affairs team at Xeltis is responsible for overseeing clinical trials and studies to evaluate the safety and efficacy of innovative heart valve therapies. This team collaborates with medical advisors and scientific experts to ensure compliance with regulatory standards, provides strategic medical insights for product development, and communicates clinical findings to support the overall mission of advancing breakthrough heart valve treatments.
Christian Spaulding
Medical Advisor
Francesco Maisano
Medical Advisor
Gregory Fontana
Medical Advisor
Martin B. Leon
Medical Advisor
Michael Colson
Chairman, Scientific Advisory ...
Michael Mack
Medical Advisor
Patrick Serruys
Medical Advisor
Paulo Neves
VP, Clinical & Medical Affairs
Rüdiger Lange
Medical Advisor
Thierry Carrel
Medical Advisor
View all